MedTrace Logo

Apioc Toric/Spherical Single Vision Contact Lens

NCT03970512 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2022-01-19

No results posted yet for this study

Summary

The Lentechs Apioc-S and Apioc-A contact lenses are made in an FDA-approved contact lens material indicated for single-vision and astigmatism. The novel lens design has a lenticular portion which is thicker than the optical portion of the lens. When applied to the eye, it is oriented in a superior position. Unlike contact lenses currently on the market, this innovative design improves lens stability by preventing lens rotation, and may improve tear flow behind the lens.

Conditions

  • Refractive Errors

Interventions

DEVICE

Apioc-A and Apioc-S Contact Lenses

Appropriately fit, document and dispense a new spherical and toric contact lens design worn for up to 35 days.

Sponsors & Collaborators

  • Lentechs, LLC

    lead INDUSTRY

Principal Investigators

  • Thomas G Quinn, OD, MS, FAAO · Drs. Quinn, Foster & Associates

  • Jason R Miller, OD, MBA · Eyecare Professionals of Powell

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-31
Primary Completion
2021-03-18
Completion
2021-03-18
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03970512 on ClinicalTrials.gov